-
Five years after the landmark Institute of Medicine report, To Err is Human: Building a Safer Health System, not enough is being done to address medication errors, warns the Institute for Safe Medication Practices (ISMP) in Huntingdon Valley, PA.
-
Liquids on floors represent the biggest risk for falls in health care facilities, but risk managers often overlook the need to assess the fall risk of a particular area with wet surfaces, not dry ones, says an expert.
-
The 2003 transplant error at Duke University Hospital in Durham, NC, that led to the appointment of a new patient safety officer at Duke University Hospital System in Durham, NC, was traced to a lack of redundancy in the system that ensured donor organs matched the patient.
-
Look ahead five to 10 years, and you may see a male contraceptive on the market, as well as a microbicide for women that offers contraception as well as female-controlled protection against HIV and other sexually transmitted diseases (STDs), say reproductive health experts.
-
-
When the first combined oral contraceptive entered the marketplace in 1960, women began taking hormonally active pills for 21 days, followed by seven days of placebo pills, or no pills at all. This 21/7 regimen resulted in regular withdrawal bleeding every month. Such regular monthly cycles are a modern phenomenon.
-
Research has been a cornerstone of contraceptive technology; the following noninclusive list includes 25 articles of note from the past 25 years. Several selections are offered by Deborah Kowal, MA, adjunct assistant professor in the Rollins School of Public Health at Emory University in Atlanta, co-author of Contraceptive Technology, and the first editor for Contraceptive Technology Update.
-
You suspect that your 17-year-old patient may have a chlamydia infection. Thanks to a nucleic acid amplification screen on a urine specimen, you are able to detect the sexually transmitted disease (STD) and report the results the next day.
-
American women are one step closer to having a contraceptive implant option with the recent Food and Drug Administration (FDA) issuance of approvable status for Implanon, the single-rod contraceptive implant from Organon (West Orange, NJ).
-
